GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abliva AB (OSTO:ABLI) » Definitions » Sale Of Investment

Abliva AB (OSTO:ABLI) Sale Of Investment : kr0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Abliva AB Sale Of Investment?

Abliva AB's sale of investment for the three months ended in Mar. 2024 was kr0.00 Mil. It means Abliva AB gained kr0.00 Mil from selling investments. Abliva AB's sale of investment for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.00 Mil.

Compared with last quarter (kr0.00 Mil in Dec. 2023 ), Abliva AB gained the same money from selling investments in Mar. 2024 (kr0.00 Mil).

Abliva AB Sale Of Investment Historical Data

The historical data trend for Abliva AB's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abliva AB Sale Of Investment Chart

Abliva AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Abliva AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Abliva AB Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abliva AB Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Abliva AB's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Abliva AB (OSTO:ABLI) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abliva AB (OSTO:ABLI) » Definitions » Sale Of Investment
Comparable Companies
OSTO:ATORX XSAT:HAMLET B OSTO:BIOWKS OSTO:MAGLE OSTO:ACOU OSTO:KAN OSTO:ACTI OSTO:CLBIO OSTO:STABL OSTO:GUARD OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
NEVPF:USA NTP:Germany
Address
Scheeletorget 1, Medicon Village, Lund, SWE, 223 81
Website
https://www.abliva.com
Abliva AB is a Swedish company that is active in pharmaceutical development. It develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare, and often very severe diseases occur when the cell's energy provider, the mitochondria, does not function properly. The portfolio includes projects at different stages and ranges from the early discovery phase to the clinical phase.

Abliva AB (OSTO:ABLI) Headlines

No Headlines